Phibro Animal Health Corp. A Stock
Phibro Animal Health Corp. A gained 1.200% today.
Our community is currently high on Phibro Animal Health Corp. A with 4 Buy predictions and 2 Sell predictions.
However, we have a potential of -31.95% for Phibro Animal Health Corp. A as the target price of 23 € is below the current price of 33.8 €.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | 1.200% | 3.086% | -2.907% | 72.165% | 5.696% | 151.128% | 95.322% |
| Rockwell Medical Inc. | -2.130% | 6.857% | 5.451% | -57.457% | 24.390% | -49.911% | -92.573% |
| Pacira Pharmaceuticals | -0.540% | -9.722% | -8.879% | -4.412% | -9.722% | -42.647% | -66.949% |
| Twist Bioscience Corp | 5.060% | 9.442% | 31.032% | -18.939% | 24.022% | 44.157% | -75.151% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat